Startseite Quantitative performance of antibody array technology in a prenatal screening setting
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Quantitative performance of antibody array technology in a prenatal screening setting

  • Wendy Rodenburg , Johan H. Reimerink , Sandra Imholz , Gert-Jan Godeke , Jeroen L.A. Pennings , Peter C.J.I. Schielen , Maria P.H. Koster und Annemieke de Vries EMAIL logo
Veröffentlicht/Copyright: 28. Oktober 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Antibody microarrays (Ab-array) represent a new, innovative proteomics platform for high-throughput protein expression profiling in body fluids. Because they allow for multiplexed measurements in small sample volumes, Ab-arrays are an interesting alternative to conventional indirect sandwich immunoassay (ELISA or DELFIA) tests in clinical or population screening if sets of markers are to be analyzed simultaneously. However, to allow implementation of Ab-arrays in clinical or population screening programs, it is of vital importance to establish that this method is both sensitive and quantitative.

Methods: This study developed and optimized a duplex Ab-array for pregnancy-associated plasma protein A (PAPP-A) and human chorion gonadotropin (fβ-hCG), two serum biomarkers currently analyzed by conventional biochemical techniques in prenatal screening. Serum samples from pregnant women, representing the dynamic range of both markers, were analyzed on Ab-arrays, and validated to the, in prenatal screening routinely applied, AutoDelfia system.

Results: Two different array hybridization conditions were tested, i.e., direct and indirect labeling, of which the indirect method displayed a sensitive and quantitative performance and a low intra- and inter-assay variation.

Conclusions: Taken together, these findings indicate that Ab-array technology is a promising alternative for ELISA or DELFIA in population screening programs, allowing future quantitative analysis of multiple biomarkers simultaneously in small volumes of serum.


Corresponding author: Dr. Annemieke de Vries, Laboratory for Health Protection Research, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands Phone: +31 30 274 3483, Fax: +31 30 274 4446

Received: 2011-6-21
Accepted: 2011-10-3
Published Online: 2011-10-28
Published in Print: 2012-02-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Editorials
  2. Biological variation and reference change values: an essential piece of the puzzle of laboratory testing
  3. Copeptin for acute coronary syndrome: diamond or decoy?
  4. Reviews
  5. Gold nanoparticles in the clinical laboratory: principles of preparation and applications
  6. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
  7. Mini Review
  8. From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach
  9. Opinion Paper
  10. Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin
  11. Perspectives
  12. Do genome-wide association scans have potential for translation?
  13. Genetics and Molecular Diagnostics
  14. Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma
  15. Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue
  16. Screening for mutations in the α-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis
  17. Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene
  18. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) –482C>T polymorphism on triglyceride concentration in Turkish adults
  19. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients
  20. Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods
  21. Functional polymorphisms of GSTA1 and GSTO2 genes associated with asthma in Italian children
  22. General Clinical Chemistry and Laboratory Medicine
  23. Optimisation of whole blood and plasma manganese assay by ICP-MS without use of a collision cell
  24. Quantitative performance of antibody array technology in a prenatal screening setting
  25. A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption
  26. A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency
  27. Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren’s syndrome patients
  28. Development of control material for hemoglobin analysis
  29. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases
  30. The effect of hematocrit on the results of measurements using glucose meters based on different techniques
  31. Lupus anticoagulant testing: analyzing fresh samples after a single centrifugation and after a 6–8 h delay
  32. Pseudoeosinophilia of synovial fluid is caused by crystals mimicking the distinct light scattering fractions of eosinophilic granules
  33. The effect of acidification and oxalate concentration on urine calcium measurements in EQAS materials and patient samples
  34. Cancer Diagnostics
  35. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease
  36. Cardiovascular Diseases
  37. Heart type fatty acid binding protein in relation to pharmacologic scintigraphy in coronary artery disease
  38. Effects of fibrates on C-reactive protein concentrations: a meta-analysis of randomized controlled trials
  39. Letters to the Editor
  40. Comparison of Bio-Plex measurements with standard techniques
  41. Interference of hemoglobin (Hb) Las Palmas with HPLC measurement of HbA1c in 87 patients
  42. False-positive calcitonin results in patients with benign goiter
  43. Erratum
  44. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  45. Congress Abstracts
  46. Advances and Controversies in B-Vitamins and Choline
  47. Prelims
Heruntergeladen am 29.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.767/html
Button zum nach oben scrollen